Related Experiment Video
Updated: Jan 7, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Social framework to judge the importance of breast cancer
Zsuzsa Réka Pozsár1, Krisztina Tóth2, Marianna Moizs3
1Center for Health Technology Assessment, Semmelweis University, Budapest, Üllői út 25, Budapest 1091, Hungary; Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Üllői út 26, Budapest 1085, Hungary; Syreon Research Institute, Budapest, Mexikói út 65/a, Budapest 1142, Hungary.
Background:
Breast cancer (BC) has profound effects on patients, households, and society, necessitating a multidimensional approach to understand its implications fully. This study aimed to develop a conceptual model for a social framework (SF) that assists in identifying group common values and needs for BC interventions in Hungary. The SF reflects diverse perspectives, including healthcare professionals, patients, caregivers, policymakers of health and social care, health technology developers, and corporate and philanthropic supporters of BC initiatives.
Methods:
A narrative literature review was conducted to identify value elements (VEs) of BC. VEs were categorized into groups and further clustered into sub-groups within each main category. This literature-based conceptual model was contextualized and adapted to the Hungarian setting through individual and group interviews with various societal group representatives. A closing validation meeting fostered stakeholders' reflection on the draft model.
Results:
The final conceptual model incorporates five traditional (e.g., clinical outcomes, adverse events, survival, and direct medical costs), nine patient-centric (e.g., personal milestones, patient experience, and financial burden), and seven societal (e.g., disease severity, the presence of the disease around us, and indirect costs) VEs.
Conclusion:
Our study is the first to present a comprehensive SF that provides insights into key disease challenges and why different BC interventions are important to various stakeholder groups via capturing traditional, patient-centric, and societal VEs. It informs decision-making within and beyond the healthcare domain by supporting the evaluation of policies, health technologies, public and civil society initiatives in Hungary.
Policy Summary:
While BC is a priority disease area for all stakeholder groups, their views on what contributes to the success of policy decisions are different. If policymakers intend to represent the interests of the whole society, they should aim to express the value of policy interventions in a comprehensive SF.
Related Concept Videos
Cancer Survival Analysis
Cancer Prevention
Some...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
